Ongoing studies into the drug are showcasing remarkable outcomes regarding body composition . Initially intended for addressing type 2 diabetes , this GLP-1 receptor agonist has shown considerable https://linkingbookmark.com/story21380272/semaglutide-research-unlocking-emerging-weight-loss-potential